Lipopeptide: Exploration for enhanced anticandidal therapeutic spectrum

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Human fungal infections, particularly from Candida albicans, are a growing threat, especially for immunocompromised individuals.
• Candida albicans forms biofilms on medical devices and within the body, conferring resistance to conventional antifungal drugs.
• Current antifungal treatments are increasingly ineffective against biofilms and exhibit rising resistance, necessitating novel therapeutic approaches.

Purpose of the Study:

• To review the structural diversity, biosynthesis, and antifungal mechanisms of lipopeptides against Candida albicans.
• To explore the potential of lipopeptides as a new class of antifungal agents to overcome drug resistance.
• To highlight the need for further research into lipopeptides for developing new treatments for invasive fungal infections.

Main Methods:

• Literature review focusing on lipopeptide structures, biosynthesis pathways, and antifungal activities.
• Analysis of studies investigating lipopeptide interactions with Candida albicans virulence factors, including biofilm formation.
• Examination of bacterial lipopeptides, such as surfactin, fengycin, iturins, and daptomycin, for their efficacy against Candida species.

Main Results:

• Lipopeptides, particularly cyclic variants from Bacillus and Pseudomonas, exhibit potent antifungal activity against Candida species.
• These lipopeptides disrupt Candida cell membranes due to their hydrophobic nature and inhibit biofilm development.
• Several lipopeptides demonstrate efficacy against virulence factors associated with Candida albicans infections.

Conclusions:

• Lipopeptides represent a promising alternative to existing antifungal drugs, with potential for treating drug-resistant fungal infections.
• Further in-depth research into lipopeptides is crucial for developing novel, safe, and broad-spectrum antifungal therapies.
• Targeting lipopeptide mechanisms could lead to new treatment strategies for invasive Candida infections, addressing the current gap in effective antifungal arsenals.